Cytosine β-D-arabinofuranoside used as a paradigm modifier to increase production of tau aggregates in a cellular model of tauopathy

Li Wen Ko, Jayanarayan G. Kulathingal, Shu Hui C Yen

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Intraneuronal deposition of filamentous tau is a hallmark of Alzheimer's disease (AD) and related tauopathies. We developed previously a cellular model recapitulating such tau anomaly and demonstrated therein consistent production of 70-kD tau. Importantly, the 70-kD species appears to derive from tau fragments with carboxy-terminal truncation and is larger than intact tau in size, suggesting the oligomeric nature in its assembly from tau. To generate the 70-kD tau in sufficient quantity for its characterization at the molecular level, we explored and demonstrated herein that cytosine β-D- arabinofuranoside is a useful paradigm modifier to increase production of the 70-kD tau. Such oligomeric tau was enriched thereafter by immunoprecipitation to remove tau species with intact carboxy-terminus. Two-dimensional gel electrophoresis revealed that the 70-kD tau has an isoelectric point of 5.8-6.0. Future elucidation of key aggregates will provide valuable insights into the natural history of neurofibrillary degeneration and identify novel targets to develop therapeutic interventions.

Original languageEnglish (US)
Pages (from-to)823-832
Number of pages10
JournalNeurochemical Research
Volume32
Issue number4-5
DOIs
StatePublished - Apr 2007

Fingerprint

Tauopathies
Cytosine
Electrophoresis, Gel, Two-Dimensional
Isoelectric Point
Natural History
Immunoprecipitation
Alzheimer Disease
Electrophoresis
Gels
Therapeutics

Keywords

  • Alzheimer's disease
  • Cellular model
  • Neurofibrillary degeneration
  • Tau
  • Tauopathy

ASJC Scopus subject areas

  • Neuroscience(all)
  • Biochemistry

Cite this

Cytosine β-D-arabinofuranoside used as a paradigm modifier to increase production of tau aggregates in a cellular model of tauopathy. / Ko, Li Wen; Kulathingal, Jayanarayan G.; Yen, Shu Hui C.

In: Neurochemical Research, Vol. 32, No. 4-5, 04.2007, p. 823-832.

Research output: Contribution to journalArticle

Ko, Li Wen ; Kulathingal, Jayanarayan G. ; Yen, Shu Hui C. / Cytosine β-D-arabinofuranoside used as a paradigm modifier to increase production of tau aggregates in a cellular model of tauopathy. In: Neurochemical Research. 2007 ; Vol. 32, No. 4-5. pp. 823-832.
@article{f03ed3ee888d48909c42d7515d5bf62d,
title = "Cytosine β-D-arabinofuranoside used as a paradigm modifier to increase production of tau aggregates in a cellular model of tauopathy",
abstract = "Intraneuronal deposition of filamentous tau is a hallmark of Alzheimer's disease (AD) and related tauopathies. We developed previously a cellular model recapitulating such tau anomaly and demonstrated therein consistent production of 70-kD tau. Importantly, the 70-kD species appears to derive from tau fragments with carboxy-terminal truncation and is larger than intact tau in size, suggesting the oligomeric nature in its assembly from tau. To generate the 70-kD tau in sufficient quantity for its characterization at the molecular level, we explored and demonstrated herein that cytosine β-D- arabinofuranoside is a useful paradigm modifier to increase production of the 70-kD tau. Such oligomeric tau was enriched thereafter by immunoprecipitation to remove tau species with intact carboxy-terminus. Two-dimensional gel electrophoresis revealed that the 70-kD tau has an isoelectric point of 5.8-6.0. Future elucidation of key aggregates will provide valuable insights into the natural history of neurofibrillary degeneration and identify novel targets to develop therapeutic interventions.",
keywords = "Alzheimer's disease, Cellular model, Neurofibrillary degeneration, Tau, Tauopathy",
author = "Ko, {Li Wen} and Kulathingal, {Jayanarayan G.} and Yen, {Shu Hui C}",
year = "2007",
month = "4",
doi = "10.1007/s11064-006-9218-4",
language = "English (US)",
volume = "32",
pages = "823--832",
journal = "Neurochemical Research",
issn = "0364-3190",
publisher = "Springer New York",
number = "4-5",

}

TY - JOUR

T1 - Cytosine β-D-arabinofuranoside used as a paradigm modifier to increase production of tau aggregates in a cellular model of tauopathy

AU - Ko, Li Wen

AU - Kulathingal, Jayanarayan G.

AU - Yen, Shu Hui C

PY - 2007/4

Y1 - 2007/4

N2 - Intraneuronal deposition of filamentous tau is a hallmark of Alzheimer's disease (AD) and related tauopathies. We developed previously a cellular model recapitulating such tau anomaly and demonstrated therein consistent production of 70-kD tau. Importantly, the 70-kD species appears to derive from tau fragments with carboxy-terminal truncation and is larger than intact tau in size, suggesting the oligomeric nature in its assembly from tau. To generate the 70-kD tau in sufficient quantity for its characterization at the molecular level, we explored and demonstrated herein that cytosine β-D- arabinofuranoside is a useful paradigm modifier to increase production of the 70-kD tau. Such oligomeric tau was enriched thereafter by immunoprecipitation to remove tau species with intact carboxy-terminus. Two-dimensional gel electrophoresis revealed that the 70-kD tau has an isoelectric point of 5.8-6.0. Future elucidation of key aggregates will provide valuable insights into the natural history of neurofibrillary degeneration and identify novel targets to develop therapeutic interventions.

AB - Intraneuronal deposition of filamentous tau is a hallmark of Alzheimer's disease (AD) and related tauopathies. We developed previously a cellular model recapitulating such tau anomaly and demonstrated therein consistent production of 70-kD tau. Importantly, the 70-kD species appears to derive from tau fragments with carboxy-terminal truncation and is larger than intact tau in size, suggesting the oligomeric nature in its assembly from tau. To generate the 70-kD tau in sufficient quantity for its characterization at the molecular level, we explored and demonstrated herein that cytosine β-D- arabinofuranoside is a useful paradigm modifier to increase production of the 70-kD tau. Such oligomeric tau was enriched thereafter by immunoprecipitation to remove tau species with intact carboxy-terminus. Two-dimensional gel electrophoresis revealed that the 70-kD tau has an isoelectric point of 5.8-6.0. Future elucidation of key aggregates will provide valuable insights into the natural history of neurofibrillary degeneration and identify novel targets to develop therapeutic interventions.

KW - Alzheimer's disease

KW - Cellular model

KW - Neurofibrillary degeneration

KW - Tau

KW - Tauopathy

UR - http://www.scopus.com/inward/record.url?scp=33947576263&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33947576263&partnerID=8YFLogxK

U2 - 10.1007/s11064-006-9218-4

DO - 10.1007/s11064-006-9218-4

M3 - Article

C2 - 17151917

AN - SCOPUS:33947576263

VL - 32

SP - 823

EP - 832

JO - Neurochemical Research

JF - Neurochemical Research

SN - 0364-3190

IS - 4-5

ER -